Nature Phyto Prostagol
Natural health product licensed in Canada
- Licence holder
- Bestin Pharma Inc.
- NPN or DIN-HM
- 80061889
- Status
- Inactive licence
- Licence date
- 16 June 2015
- Revision date
- Not provided
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cucurbita pepo Source : Cucurbita pepo - Graine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 3,334 milligramme | 166.7 milligramme | Not calculated |
| Matricaria chamomilla Source : Matricaria chamomilla, fleur Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 1,500 milligramme | 100 milligramme | Not calculated |
| Urtica dioica Source : Racine Extraction ratio : 2:1 Dry plant equivalent : 200 milligramme | 100 milligramme | Not calculated |
Non-medicinal ingredients
PVP, Stéarate de magnésium, Amidon de maïs modifié, C.I. n° 77947, Cellulose microcristalline, Oxyde de fer (Fe2O3)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80061889
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.